Maternal diabetes as a teratogenic factor in fetal congenital heart disease: more than hyperglycemia

F. Jiang,D.‐Z. Li

DOI: https://doi.org/10.1002/uog.27578

2024-03-03

Ultrasound in Obstetrics and Gynecology

Abstract:Ultrasound in Obstetrics &Gynecology, Volume 63, Issue 3, Page 426-427, March 2024.

radiology, nuclear medicine & medical imaging,obstetrics & gynecology,acoustics

What problem does this paper attempt to address?

Long-term Outcomes and Potential Mechanisms of Offspring Exposed to Intrauterine Hyperglycemia

Yi-Shang Yan,Chun Feng,Dan-Qing Yu,Shen Tian,Yin Zhou,Yi-Ting Huang,Yi-Ting Cai,Jian Chen,Miao-Miao Zhu,Min Jin

DOI: https://doi.org/10.3389/fnut.2023.1067282

IF: 5

2023-01-01

Frontiers in Nutrition

Abstract:Diabetes mellitus during pregnancy, which can be classified into pregestational diabetes and gestational diabetes, has become much more prevalent worldwide. Maternal diabetes fosters an intrauterine abnormal environment for fetus, which not only influences pregnancy outcomes, but also leads to fetal anomaly and development of diseases in later life, such as metabolic and cardiovascular diseases, neuropsychiatric outcomes, reproduction malformation, and immune dysfunction. The underlying mechanisms are comprehensive and ambiguous, which mainly focus on microbiota, inflammation, reactive oxygen species, cell viability, and epigenetics. This review concluded with the influence of intrauterine hyperglycemia on fetal structure development and organ function on later life and outlined potential mechanisms that underpin the development of diseases in adulthood. Maternal diabetes leaves an effect that continues generations after generations through gametes, thus more attention should be paid to the prevention and treatment of diabetes to rescue the pathological attacks of maternal diabetes from the offspring.
Impact of Maternal Diabetes Mellitus on Neonatal Outcomes among Infants <32 Weeks of Gestation in China: A Multicenter Cohort Study

Jing Yuan,Xinyue Gu,Jie Yang,Xinzhu Lin,Jingfei Hu,Siyuan Jiang,Lizhong Du,Wenhao Zhou,Yun K. Cao,Shoo K. Lee,Ruobing Shan,Lan Zhang

DOI: https://doi.org/10.1055/s-0043-1771501

2024-01-01

American Journal of Perinatology

Abstract:Objective Our study aimed to determine the relationship between maternal diabetes mellitus (MDM) and mortality and major morbidities for very preterm infants, as well as the effects of insulin-treated MDM, in the Chinese population.Study Design This retrospective cohort study included all preterm infants born at 24 (0/7) to 31 (6/7) weeks of gestation and admitted to 57 tertiary neonatal intensive care units participating in the Chinese Neonatal Network in 2019. All infants were followed up until discharging from the hospitals.Results A total of 9,244 very preterm infants were enrolled, with 1,584 (17.1%) born to mothers with MDM. The rates of mortality or any major morbidity in the MDM and non-MDM groups were 45.9% (727/1,584) and 48.1% (3,682/7,660), respectively. After adjustment, the risk of mortality or any morbidity was not significantly increased in the MDM group (adjusted odds ratio [aOR], 1.07; 95% confidence interval [CI], 0.94-1.22) compared with the non-MDM group. Among MDM mothers with treatment data, 18.0% (256/1,420) were treated with insulin. Insulin-treated MDM was not independently associated with the risk of mortality or any morbidity (aOR, 1.01; 95% CI, 0.76-1.34) among very preterm infants, but it was associated with an elevated risk of severe retinopathy of prematurity (aOR, 2.39; 95% CI, 1.13-5.04).Conclusion While the MDM diagnostic rate for mothers of very preterm infants was high in China, MDM was not associated with mortality or major morbidities for very preterm infants.
The Association of Gestational Diabetes Mellitus with Fetal Birth Weight.

Yi Yang,Zhaopin Wang,Minjia Mo,Xiamusiye Muyiduli,Shuojia Wang,Minchao Li,Shuying Jiang,Yimin Wu,Bule Shao,Yu Shen,Yunxian Yu

DOI: https://doi.org/10.1016/j.jdiacomp.2018.04.008

IF: 3.219

2018-01-01

Journal of Diabetes and its Complications

Abstract:Aims: Gestational diabetes mellitus (GDM) and different time-point glucose levels might have different effects on fetal birth weight. The aim of this study was to further evaluate the associations of GDM and different time-point blood glucose levels with fetal birth weight in a prospective cohort study. Methods: This prospective cohort study was conducted in Zhoushan Maternal and Child Health Hospital, Zhejiang, from August 2011 to May 2015.1232 pairs of singleton, full-term newborns and their mothers without other pregnant and perinatal complications were selected as participants. Results: Of the 1232 women, 234 had GDM. GDM was positively associated with birth weight (beta = 99.5 g, P = 0.0002), gestational age-specific Z-score of birth weight (beta = 0.23, P = 0.0003), and an increased risk of large for gestational age (LGA; OR = 1.79,95%CI: 1.11-2.89) and macrosomia (OR = 2.13,95%CI:1.34-3.40). Compared with abnormal fasting plasma glucose (FPG) during the second trimester, abnormal postload glucose in oral glucose tolerance test had significantly higher birth weight and gestational age-specific Z-score of birth weight, and an increased risk of macrosomia. Abnormal FPG and abnormal postload glucose had significantly joint effect on birth weight (beta = 161.4 g, P = 0.0192), gestational age-specific Z-score of birth weight (beta = 0.42, P = 0.0121) and risk of macrosomia (OR = 3.24,95%CI: 1.21-8.67) and LGA (OR = 5.73,95%CI: 2.20-14.90). Compared with abnormal blood glucose during the first trimester, GDM had significantly higher birth weight and gestational age-specific Z-score of birth weight. Abnormal blood glucose during the first trimester and GDM had significantly joint effect on birth weight (beta = 125.8 g, P = 0.0010), gestational age-specific Z-score of birth weight (beta = 0.30, P = 0.0013) and risk of macrosomia (OR = 2.34, 95%CI: 1.28-4.30) and LGA (OR = 2.53, 95%CI: 1.37-4.67). However, we did not find blood glucose during the first trimester independently associated with birth weight. Conclusions: GDM was significantly associated with higher birth weight and an increased risk of LGA and macrosomia. Fetal growth was mostly influenced by postload glucose levels, rather than FBG. Moreover, different time-point blood glucose levels had significantly joint effects on birth weight and risk of LGA and macrosomia. (C) 2018 Elsevier Inc. All rights reserved.
Impact of Family History of Diabetes on Blood Glucose, Lipid Levels and Perinatal Outcomes in Pregnant Women with Gestational Diabetes Mellitus.

Yumei Zhou,Ni Xie,Lixia Zhang,Danqing Chen

DOI: https://doi.org/10.3724/zdxbyxb-2021-0193

2021-01-01

Abstract:To investigate the impact of family history of diabetes (FHD) on blood glucose, lipid levels and perinatal outcomes in pregnant women with gestational diabetes mellitus (GDM). A total of 1265 GDM women who gave childbirth in Women's Hospital, Zhejiang University School of Medicine during January to December 2019 were enrolled in the study, including 253 women with FHD and 1012 women without FHD. The -test or test were used to compare the blood lipid, blood glucose levels and perinatal outcomes including large for gestational age infant, small for gestational age infant, macrosomia, cesarean delivery, preeclampsia, preterm labor, postpartum hemorrhage, fetal distress. The correlation between FHD and perinatal outcomes were estimated by Logistic regression analysis. The high density lipoprotein level at third-trimester was significantly lower in GDM women with FHD (<0.05); and the women with FHD also had higher fasting blood glucose oral glucose tolerance test (OGTT)1 h, OGTT 2 h and glycosylated hemoglobin level (all <0.01). In GDM women, FHD was an independent risk factor for preeclampsia (=3.27, 95%: 1.39-7.68). GDM women with FHD have lower high density lipoprotein and higher glucose levels. FHD is an independent risk factor for preeclampsia in GDM women.
Maternal Gestational Diabetes Mellitus and Congenital Heart Disease in Offspring: A Meta-Analysis

Yun Liu,Lina Yue,Li Chang

DOI: https://doi.org/10.1055/a-2238-1710

2024-02-04

Hormone and Metabolic Research

Abstract:Maternal diabetes has been related to an increased risk of congenital heart disease (CHD) in offspring. However, inconsistent results were retrieved for studies evaluating the association between gestational diabetes mellitus (GDM) and CHD in offspring. We therefore performed a systematic review and meta-analysis for comprehensive investigation. Observational studies were identified by searching PubMed, Embase, and Web of Science according to the aim of the meta-analysis. A randomized-effects model was used to pool the data by incorporating the influence of potential heterogeneity. Twenty-three observational studies, involving 46953078 mother-child pairs, were available for the meta-analysis. Among them, 2131800 mothers were diagnosed as GDM and 214379 newborns had CHD. Overall, maternal GDM was associated with a higher incidence of CHD in offspring [odds ratio (OR): 1.32, 95% confidence interval (CI): 1.21 to 1.45, p<0.001; I2=62%]. Sensitivity analysis limited to studies with adjustment of maternal age and other potential confounding factors showed similar results (OR: 1.40, 95% CI: 1.30 to 1.51, p 0.05). Subsequent analysis according to types of CHD showed that maternal GDM was associated with higher risks of atrial septal defect, ventricular septal defect, and Tetralogy of Fallot. Maternal GDM may be associated with a higher risk of CHD in offspring. Received: 05 October 2023 Accepted after revision: 15 December 2023 Article published online: 02 February 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, Germany

endocrinology & metabolism
Clinical significance of ultrasonic umbilical artery flow analysis in pregnancy with gestational diabetes mellitus

Ke ZHANG,Ming-zhu GE,Jing HE,Fang WANG,Dan-qing CHEN

DOI: https://doi.org/10.3321/j.issn:0376-2491.2008.05.008

2008-01-01

Abstract:objective To investigate the clinical significance of ultrasonic umbilical artery flow analysis in pregnaney with gestational diabetes mellitus(GDM).Methods Ultrasonic Doppler umbilical artery blood flowmeter was used to detect the systolic/diastolic blood pressure(S/D)ratio,pulse index,and resistance index of umbilical artery in 102 GDM women,aged(29±4),and 105 aged-matched normal pregnant women.The delivering and pefinatal outcomes were observed. Results The S/D ratio,pulse index.and resistance index of the GDM women were 2.55±0.52,1.03±0.23,and 0.59±0.68respectively,all significantly higher than those of the control group(2.11±0.22,0.81±0.13,and 0.52±0.47 respectively.all P＜0.01.The rates of premature rupture of fetal membrane,postpartum hemerrhage,fetal macrosomia,and bad outcome of perinatal infant in the GDM group were 12.7%,7.8%,17.7%,and 12.7%respectively,all significantly higher than those in the control group(1.9%,1.9%,6.7%,and 1.9%,all P＜0.05).The rates of premature labor,premature rupture of fetal membrane,postpartum hemorrhage,fetal macrosomia,and bad outcome of pefinatal infant of the GDM women with the S/D.S/D≥2.5(n=47)were 36.2%,21.3%,17.0%,55.3%,and 21.3%respectively,all significantly higher than those of the GDM women with the S/D＜2.5(n=55)12.7%,3.6%,1.8%,7.3%and 3.6%,(all P＜0.05).Conclusion Ultrasonic umbilical artery flow analysis in pregnancy with GDM is a good method to forecast the placenta function and perinatal outcomes.The poor perinatal outcome is associated with the S/D≥2.5 in GDM.
Impact of maternal diabetes mellitus on fetal atrial strain

Faraz Pathan,Penny Lam,Shanthosh Sivapathan,Shahab Pathan,Zhiyu Gao,Sam Orde,Deva Nirthanakumaran,Kazuaki Negishi,Ralph Nanan

DOI: https://doi.org/10.1007/s10554-024-03194-9

2024-07-27

Abstract:While Maternal Diabetes Mellitus (DM) is well known to affect the size and function of multiple fetal organ systems, effects on developing heart chamber function remain difficult to assess. We sought to determine the independent impact of maternal DM on fetal cardiac function in middle pregnancy. We prospectively recruited mothers with all categories of DM and non-diabetic healthy controls (NDC). Echocardiograms were optimized for chamber quantification and strain analysis. Left atrial area (LAA), LA strain (LAS), right atrial strain (RAS), global longitudinal ventricular strain (GLS) and Right ventricular free wall strain (RV FWS) were evaluated by 2 blinded operators. After excluding 9 mothers with poor fetal image quality, images from 104 mothers with DM and 47 NDC were analyzed. Mothers with DM and NDCs were well matched for age, blood pressure, smoking prevalence, and gestational age. Fetal heart rate (FHR) was significantly higher in fetuses of mothers with DM compared to NDC (147 ± 10 bpm vs. 144 ± 8, p = 0.04). LAA in fetuses of mothers with DM trended towards being larger in size (1.68 ± 0.4cm2 vs. 1.56 ± 0.4cm2, p = 0.08). Fetal septal diameters were larger in maternal DM compared to NDC (2.7 ± 0.5 cm vs. 2.5 ± 0.5 cm, p = 0.001). GLS was similar between the groups. Fetal LAS was lower in maternal DM (28.8 ± 8.8% vs. 33.3 ± 10.4%, p = 0.007) and was independently associated with maternal DM after adjusting for GLS and FHR. Fetal RAS was lower in maternal DM (27.7 ± 10.4% vs. 31.8 ± 10.3%, p = 0.007), however only determinates were estimated fetal weight and RV FWS. Maternal DM independently impairs fetal LA function in mid pregnancy. These early functional changes in the developing heart warrant future studies investigating impact on cardiovascular health.
The Impacts of Maternal Gestational Diabetes Mellitus (GDM) on Fetal Hearts

Chu Chen,Gui Yong Hao,Yun,Shi Li Ye

DOI: https://doi.org/10.3967/0895-3988.2012.01.003

2012-01-01

Abstract:OBJECTIVE:To evaluate the fetal cardiac function in gestational diabetes mellitus (GDM) pregnancies under different maternal glycemic controls. METHODS:Forty four GDM mothers received 78 fetal echocardiographic evaluations at three gestational periods (<28, 28-34 and >34 weeks) and were divided into poorly-(DM1) and well-(DM2) controlled groups according to their glycemic control at examination. Seventy uncomplicated mothers were selected as controls. Parameters of fetal cardiac anatomy and function were measured and analyzed. RESULTS:GDM fetuses' cardiac ventricular walls were thicker than controls', and the differences between DM1 and DM2 were not significant except for end-diastolic left ventricular walls. In both GDM groups, the aortic flow velocities increased earlier than pulmonary artery and DM1 fetuses changed earlier than DM2 ones. GDM fetuses' left atrial shortening fraction was smaller than the controls' in the period of ⩾34 weeks and negatively correlated with thicknesses of left ventricular walls and interventricular septum in DM1 fetuses (r=-0.438 and -0.506). The right ventricular diastolic function in DM1 and DM2 fetuses decreased after the period of 28-34 weeks and in the period of >34 weeks respectively. Tei index of both left and right ventricles increased in DM1 group after the period of <28 weeks and in DM2 group only in the period of ⩾34 weeks, with no significant differences between DM1 and DM2 groups in this period. CONCLUSION:Fetuses of GDM mothers showed cardiac function impairments. Good maternal glycemic control may delay the impairments, but cannot reduce the degree. Some cardiac changes in GDM fetuses were similar to those in pregestational diabetic pregnancies except for several parameters and their changing time.
Pathophysiological Role of Fetal Glucose Steal in Diabetes in Pregnancy and Its Clinical Implication

Jingjing LI,Jing LU,Yan BI,Dalong ZHU

DOI: https://doi.org/10.3969/j.issn.1006-2084.2018.05.001

2018-01-01

Abstract:Diabetes in pregnancy is associated with significantly increased risks of adverse perinatal outcomes.Proper glycemic control during pregnancy improves neonatal outcomes but only to a limited extent.Current research is focused mostly on maternal hyperglycemia and the consequential disturbance of uterine environment.However,the potentially predominant role of the fetus in the pathophysiology of diabetic pregnancy is rarely mentioned.Fetal glucose steal is the course which the fetus drives glucose flux from the mother by the maternal -to-fetal glucose concentration gradient.The steep-ness of this gradient and effect of fetal glucose steal will be greatest when maternal hyperglycemia and fetal hyperinsulinemia coexist,further leading to the development of diabetic fetopathy.Therefore,it is vital to prevent early establishment of fetal hyperinsulinemia,which requires screening of women at-risk and optimized intervention before and during early pregnancy. Besides,maternal glucose levels can be attenuated due to intensive fetal glucose steal,thus more precise biomarkers are required for the diagnosis of diabetes and assessment of glycemic control during pregnancy.
Updates in Long-term Maternal and Fetal Adverse Effects of Gestational Diabetes Mellitus

Chong Shou,Yueguang Wei,Chen Wang,Huixia Yang

DOI: https://doi.org/10.1097/fm9.0000000000000019

2019-01-01

Maternal-Fetal Medicine

Abstract:Gestational diabetes mellitus (GDM) is associated with long-term maternal and fetal adverse outcomes. Recent evidences suggest GDM increases long-term maternal cardiovascular disease, chronic kidney disease, and cancer risks. Maternal hyperglycemia is associated with offspring obesity, overweight, insulin resistance, and neurocognitive development. It remains unclear whether treating mild GDM would reduce long-term maternal and fetal adverse effects.
Decreased Fetal Pre-Adipocyte Factor-1 in Pregnancies Complicated by Gestational Diabetes Mellitus

Jie Li,Qiuyuan Zhu,Hanzhi Wang,Cong Han,Qunyan Zhou,Hefeng Huang,Minyue Dong

DOI: https://doi.org/10.1016/j.cca.2014.01.048

IF: 6.314

2014-01-01

Clinica Chimica Acta

Abstract:Background: Serum pre-adipocyte factor-1 (pref-1) is an inhibitor of adipocyte differentiation that increases in small for gestational age fetuses. It plays a role in adipose metabolism and is associated with an increased risk of metabolic diseases in adulthood. We hypothesized that preadipocyte factor-1 (pref-1) concentration is altered in fetuses born to women with gestational diabetes mellitus (GDM).Methods: Umbilical cord blood pref-1 concentrations were determined by enzyme-linked immunosorbant assay in 37 fetuses from pregnancies complicated by GDM and 45 fetuses from normal pregnancies.Results: Serum pref-1 concentrations were significantly lower in fetuses of women with GDM compared to normal pregnancies (16.12 +/- 6.48 vs. 22.09 +/- 7.22 mu g/l, P = 0.001). Birth weight was significantly higher in GDM fetuses compared to normal pregnancies (3567 +/- 544 vs. 3253 +/- 370 g, P = 0.003).Conclusions: Pregnancies complicated by GDM have decreased fetal pref-1 concentrations compared to normal pregnancies. These differences may be significant in terms of their later development of metabolic conditions. (C) 2014 Elsevier B.V. All rights reserved.
Imaging Review of Obstetric Sequelae of Maternal Diabetes Mellitus

Hassan Aboughalia,Priya Pathak,Deepashri Basavalingu,Teresa Chapman,Margarita V Revzin,Laura E Sienas,Gail H Deutsch,Douglas S Katz,Mariam Moshiri

DOI: https://doi.org/10.1148/rg.210164

Radiographics

Abstract:Diabetes mellitus, whether preexisting or gestational, poses significant risk to both the mother and the developing fetus. A myriad of potential fetal complications in the setting of diabetic pregnancies include, among others, congenital anomalies, delayed fetal lung maturity, macrosomia, and increased perinatal morbidity and mortality. Congenital anomalies most commonly involve the nervous, cardiovascular, genitourinary, and musculoskeletal systems. Delayed fetal lung maturity, probably secondary to hyperglycemia suppressing surfactant secretion, is a major determinant of perinatal morbidity and mortality. Besides the potential complications encountered during cesarean delivery in macrosomic fetuses, vaginal delivery is also associated with increased risks of shoulder dystocia, clavicular and humeral fractures, and brachial plexus palsy. Maternal complications are related to the increased risk of hypertensive diseases of pregnancy and associated preeclampsia and hemolysis, elevated liver function, and low platelets (HELLP) syndrome, as well as complications encountered at the time of delivery secondary to fetal macrosomia and cesarean delivery. Additional conditions encountered in the setting of maternal diabetes include polyhydramnios, placental thickening, and two-vessel umbilical cord, each of which is associated with adverse fetal and maternal outcomes including fetal growth restriction, preterm labor, placental abruption, and premature rupture of membranes. Imaging plays a vital role in the evaluation of the mother and the fetus and can provide invaluable information that can be used by maternal fetal medicine to manage this patient population effectively. The authors review the pathophysiologic alterations induced by diabetes in pregnancy, discuss the imaging spectrum of diabetic embryopathy, and provide a detailed review of potential associated maternal complications. Online supplemental material is available for this article. ©RSNA, 2021.
Ultrasonographic diagnosis of fetal hemodynamic parameters in pregnant women with diabetes mellitus in the third trimester of pregnancy

Dongmei Cai,Su Yan

DOI: https://doi.org/10.1016/j.heliyon.2024.e30352

IF: 3.776

2024-04-25

Heliyon

Abstract:Objective: It was to investigate the diagnosis of fetal hemodynamics in pregnant women with diabetes mellitus in the third trimester of pregnancy by color Doppler ultrasonography. Methods: 55 women with gestational diabetes mellitus (GDM) in the third trimester of pregnancy who were clinically diagnosed and treated in Haian City People's Hospital of Jiangsu Province were selected as the observation group, and 55 pregnant women with normal prenatal examination results were selected as the controls. The hemodynamic parameters of fetal middle cerebral artery (MCA), umbilical artery (UA), and renal artery (RA) were detected, including the ratio of maximum systolic blood flow velocity to end-diastolic blood flow velocity (S/D), resistance index (RI) and arterial pulsation index (PI). Fasting serum levels of maternal patients were collected for detecting Cystain C (Cys C) and homocysteine (Hcy) to analyze the predictive value of serological indexes and target arterial hemodynamics parameters for adverse pregnancy outcome (APO). Results: The results showed that compared with controls, in the observation group, RI, PI, and S/D of MCA and RA increased significantly, while RI, PI and S/D of UA decreased obviously (P < 0.05), the levels of serum Cys C and Hcy were clearly increased (P < 0.05). The APO rate of controls and observation group was 10.91 % and 25.45 %, respectively. It was found that the area under the curve of serum Cys C, Hcy, and the APO predicted by the hemodynamic parameters of fetal MCA, UA, and RA were all greater than 0.75 (P < 0.05). Multiple Logistic regression analysis showed that serum Cys C and Hcy, and the hemodynamic parameters of fetal MCA, UA and RA were correlated with APO (P < 0.05). Conclusion: In summary, maternal blood glucose level can affect fetal hemodynamic parameters. In the third trimester of pregnancy, the changes of blood flow parameters of fetal MCA, UA, RA, and maternal serum Cys C and Hcy levels are helpful to understand fetal status in utero, and can be used to predict APO.
Mechanisms of Congenital Malformations in Pregnancies with Pre-existing Diabetes

Mary R. Loeken

DOI: https://doi.org/10.1007/s11892-020-01338-4

2020-09-12

Current Diabetes Reports

Abstract:Fetuses of diabetic mothers are at increased risk for congenital malformations. Research in recent decades using animal and embryonic stem cell models has revealed many embryonic developmental processes that are disturbed by maternal diabetes. The aim of this review is to give clinicians a better understanding of the reasons for rigorous glycemic control in early pregnancy, and to provide background to guide future research.

endocrinology & metabolism
"Maternal diabetes mellitus and its impact on the risk of delivering a child with congenital heart disease: a systematic review and meta-analysis"

Andreas S Papazoglou,Dimitrios V Moysidis,Periklis Panagopoulos,Eleftherios G Kaklamanos,Christos Tsagkaris,Ioannis Vouloagkas,Efstratios Karagiannidis,Georgios I Tagarakis,Theodora Papamitsou,Ioannis G Papanikolaou,Chryssi Christodoulaki,Nikolaos Vrachnis

DOI: https://doi.org/10.1080/14767058.2021.1960968

Abstract:Aim: Maternal pregestational diabetes mellitus (PGDM), type 1 or type 2, has been established as a potential risk factor for congenital heart disease (CHD). At the same time, the correlation between gestational diabetes mellitus (GDM) and increased risk of CHD has not been yet fully elucidated. The objective of this systematic review and meta-analysis (PROSPERO number: CRD42020182390) was to analyze the existing evidence on PGDM and to attempt to fill, to the best of our ability, the remaining knowledge gap in the association of GDM with CHD. Materials and methods: Two authors have independently searched the Pubmed/Medline, Scopus, Cochrane, Web of Science, and Theses Global databases with keywords and Boolean operators. The search yielded 9333 relevant articles, which were later screened for eligibility. Original peer-reviewed (case-control or cohort) studies were included if they were published in English between 1997 and 2020. Thirteen studies on mothers with PGDM and seven studies on mothers with GDM were finally included in our meta-analysis to investigate the association of maternal diabetes with the risk of delivering a child with CHD. The selected studies were all assessed for their methodological quality using the Newcastle-Ottawa scale. Associations with p < .05 were considered statistically significant. Results: Our meta-analysis (I2 > 75%, total population: n = 12,461,586) of 79,476 women with PGDM and 160,893 with GDM produced an odds ratio of 3.48 (2.36-4.61) and 1.55 (1.48-1.61), respectively. Additionally, we did not find any noticeable difference in the risk for CHD among diabetic women living in the USA and Europe. Nevertheless, it still needs to be clarified, whether or not the gestational diabetic population includes undiagnosed women with preexisting diabetes, which might account for the increased risk of delivering a child with CHD in women classified as suffering from GDM. Conclusion: While both GDM and PGDM seem to significantly increase the risk of CHD in comparison with the general population, PDGM appears to have a greater association with CHD, being correlated with a 3.5-fold increase in the risk of malformation. Preconceptional and gestational diabetes care are, therefore, essential to mitigate the adverse effect of hyperglycemia on fetal heart formation during pregnancy.
Impact of maternal diabetes and obesity on fetal cardiac functions

Suzan Bayoumy,Marwa Habib,Randa Abdelmageed

DOI: https://doi.org/10.1186/s43044-020-00077-x

2020-07-31

Abstract:Background: In several developing industrial countries, the incidence of obesity among populations is spreading quickly and dramatically; also, the frequency of maternal obesity is in continuous elevation, which represents a considerable public health problem. Maternal hyperglycemia is a common gestational risk factor for the fetus. Several studies proposed that maternal DM and obesity lead to intrauterine impacts which induce changes in the fetal myocardium, and the pre-pregnancy obesity and diabetes are accompanied with development of cardiovascular alterations in the offspring and subsequent pathological changes in their early life. The aim of this study is to assess the cardiac function in fetuses of obese pregnant women (FOW) and fetuses of diabetic women (FDW) in comparison with fetuses of normal pregnant women (FNW) using tissue Doppler imaging. Results: There was impairment in systolic and diastolic cardiac function in both fetuses of obese and diabetic women with decreased global longitudinal strain tissue Doppler velocities at 30 weeks of gestation compared to fetuses of normal women. Conclusion: Imaging of the fetus of pregnant women by Echo Doppler at about 30 weeks of gestations showed a reduced cardiac function of fetuses of obese and diabetic women matched with fetuses of normal BMI women. Our finding proposed that early subclinical alterations in the fetal cardiac output can arise from maternal obesity alone. This explains the predilection of children of obese mothers at advanced ages to cardiovascular disorder.
Maternal glycemic profiles during pregnancy and predelivery correlate with neonatal glucose homeostasis and jaundice risk: a prospective cohort study

Yan Zhang,Xing Li,Zhuyuan Zhang,Hao Wu

DOI: https://doi.org/10.21037/tp-24-356

2024-11-29

Translational Pediatrics

Abstract:Keywords: Diabetic pregnancy; glycemic management; neonatal hypoglycemia; neonatal jaundice; prospective study

pediatrics
Maternal Gestational Diabetes is Associated with Offspring’s Hypertension

Jun Lu,Shuang Zhang,Weiqin Li,Junhong Leng,Leishen Wang,Huikun Liu,Wei Li,Cuiping Zhang,Lu Qi,Jaakko Tuomilehto,Jinbo Chen,Xilin Yang,Zhijie Yu,Gang Hu

DOI: https://doi.org/10.1093/ajh/hpz005

2019-01-01

American Journal of Hypertension

Abstract:OBJECTIVE Several studies assessed maternal gestational diabetes mellitus (GDM) with the risk of childhood high blood pressure, and the results were inconsistent. We investigated the association between maternal GDM and hypertension risk in offspring during early childhood. METHODS We performed a large study in 1,156 mother-child pairs (578 GDM and 578 non-GDM matched by their offspring's age and sex). Maternal GDM was diagnosed according to the World Health Organization criteria. Childhood height, weight, and blood pressure were measured using standardized methods. Age-, sex-, and height-specific blood pressure Z score, childhood hypertension, and high blood pressure were evaluated according to the reference range of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. RESULTS After adjustment for maternal and children's characteristics, children born to mothers with GDM during pregnancy had higher mean values of systolic blood pressure Z score (0.09 vs. -0.17), and higher prevalence of hypertension (6.4% vs. 3.5%) and high blood pressure (15.6% vs. 9.3%) in comparison with their counterparts born to mothers without GDM during pregnancy (all P values <0.05). Multivariable-adjusted odds ratios among children of mothers with GDM compared with children of mothers without GDM were 2.32 (95% confidence intervals [CI] 1.16-4.62) for hypertension and 1.89 (95% CI 1.24-2.86) for high blood pressure, respectively. CONCLUSIONS Maternal GDM was associated with an increased risk of hypertension in the offspring. Controlling maternal GDM may be important for preventing childhood hypertension in the affected offspring.
Maternal Diabetes and Risk of Hypospadias: A Systemic Review and Meta-Analysis

Zhiyuan Liu,Chengjun Yu,Shuhan Yang,Jin Luo,Jie Zhang,Xiao Wang,Chun Wei,Qinlin Shi,Yi Hua,Xing Liu,Guanghui Wei

DOI: https://doi.org/10.1159/000536078

2024-01-15

Urologia Internationalis

Abstract:Introduction: This study aimed to investigate the association between maternal diabetes and the risk of hypospadias in male infants, as the relationship between them remains uncertain. Methods: To comprehensively evaluate the association between pregestational diabetes mellitus and gestational diabetes mellitus with hypospadias, we conducted a systematic review and meta-analysis. A thorough literature search was conducted, encompassing relevant publications published prior to January 2023. Crude odds ratios (ORs) and their corresponding 95% confidence intervals (CIs) were calculated using a random-effects model. Results: Our meta-analysis comprised a total of 13 studies, 11 of which investigated the relationship between pregestational diabetes mellitus and hypospadias, while 9 studies explored the association between gestational diabetes mellitus and hypospadias. Notably, these investigations yielded compelling evidence of significant positive associations between pregestational diabetes mellitus and hypospadias (OR = 1.51, 95% CI = 1.13–2.03), as well as between gestational diabetes mellitus and hypospadias (OR = 1.18, 95% CI = 1.04–1.35). Conclusion: Our findings suggest that both pregestational diabetes mellitus and gestational diabetes mellitus are associated with an increased risk of hypospadias in offspring. Further investigations are needed to explore the optimal range of blood glucose during pregnancy that minimizes the risk of congenital malformation in the fetus, as well as to develop more effective measures for glycemic control in pregnant women.

urology & nephrology
EP09.111: Ultrasound examination of fetal myocardium to screen out pregnancy complication in gestational diabetes mellitus

A. Suranyi,Z. Pál,Z. Kádas,S. Várbíró,G. Németh,Z. Kozinszky

DOI: https://doi.org/10.1002/uog.28492

2024-09-11

Ultrasound in Obstetrics and Gynecology

Abstract:Ultrasound in Obstetrics &Gynecology, Volume 64, Issue S1, Page 223-224, September 2024.

radiology, nuclear medicine & medical imaging,obstetrics & gynecology,acoustics

Maternal diabetes as a teratogenic factor in fetal congenital heart disease: more than hyperglycemia

Long-term Outcomes and Potential Mechanisms of Offspring Exposed to Intrauterine Hyperglycemia

Impact of Maternal Diabetes Mellitus on Neonatal Outcomes among Infants &lt;32 Weeks of Gestation in China: A Multicenter Cohort Study

The Association of Gestational Diabetes Mellitus with Fetal Birth Weight.

Impact of Family History of Diabetes on Blood Glucose, Lipid Levels and Perinatal Outcomes in Pregnant Women with Gestational Diabetes Mellitus.

Maternal Gestational Diabetes Mellitus and Congenital Heart Disease in Offspring: A Meta-Analysis

Clinical significance of ultrasonic umbilical artery flow analysis in pregnancy with gestational diabetes mellitus

Impact of maternal diabetes mellitus on fetal atrial strain

The Impacts of Maternal Gestational Diabetes Mellitus (GDM) on Fetal Hearts

Pathophysiological Role of Fetal Glucose Steal in Diabetes in Pregnancy and Its Clinical Implication

Updates in Long-term Maternal and Fetal Adverse Effects of Gestational Diabetes Mellitus

Decreased Fetal Pre-Adipocyte Factor-1 in Pregnancies Complicated by Gestational Diabetes Mellitus

Imaging Review of Obstetric Sequelae of Maternal Diabetes Mellitus

Ultrasonographic diagnosis of fetal hemodynamic parameters in pregnant women with diabetes mellitus in the third trimester of pregnancy

Mechanisms of Congenital Malformations in Pregnancies with Pre-existing Diabetes

"Maternal diabetes mellitus and its impact on the risk of delivering a child with congenital heart disease: a systematic review and meta-analysis"

Impact of maternal diabetes and obesity on fetal cardiac functions

Maternal glycemic profiles during pregnancy and predelivery correlate with neonatal glucose homeostasis and jaundice risk: a prospective cohort study

Maternal Gestational Diabetes is Associated with Offspring’s Hypertension

Maternal Diabetes and Risk of Hypospadias: A Systemic Review and Meta-Analysis

EP09.111: Ultrasound examination of fetal myocardium to screen out pregnancy complication in gestational diabetes mellitus

Impact of Maternal Diabetes Mellitus on Neonatal Outcomes among Infants <32 Weeks of Gestation in China: A Multicenter Cohort Study